iSpecimen logo

iSpecimenNASDAQ: ISPC

Profile

Sector:

Healthcare

Country:

United States

IPO:

17 June 2021

Next earnings report:

N/A

Last dividends:

N/A

Next dividends:

N/A
$4.15 M
-97%vs. 3y high
11%vs. sector
-vs. 3y high
-vs. sector
-92%vs. 3y high
36%vs. sector
-96%vs. 3y high
10%vs. sector

Price

after hours | 54 min ago
$4.31-$0.10(-2.27%)

Dividend

No data over the past 3 years
$2.66 M$2.98 M
$2.66 M-$1.44 M

Analysts recommendations

Institutional Ownership

ISPC Latest News

iSpecimen Named Top Competitor in $4.4 Billion USD Market
newsfilecorp.com08 November 2024 Sentiment: POSITIVE

Biospecimen Market To Exceed $13.5 Billion USD By 2032 Woburn, Massachusetts--(Newsfile Corp. - November 8, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the addressable Biospecimen contract research services market is attractive and growing. In fact, according to AceInsight Analytic, the market is presently valued at USD 4.4 billion as of 2023 and is predicted to reach USD 13.5 billion by the year 2032, growing at a 13.3% CAGR during the forecast period.

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually
globenewswire.com07 November 2024 Sentiment: POSITIVE

WOBURN, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today a significant enhancement to its searchable inventory that provides researchers with increased access to a wide array of biospecimens vital to advancing oncology research and treatments.

iSpecimen Announces 1-for-20 Reverse Stock Split
globenewswire.com11 September 2024 Sentiment: NEUTRAL

WOBURN, Mass., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc.  (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers,  announced today that it will effect a reverse stock split of its issued and outstanding shares of common stock, par value $0.0001 per share, as well as any shares of common stock held by the Company in treasury, at a ratio of 1-for-20. The reverse stock split will become effective at 4:30 p.m. Eastern Time on September 13, 2024, and the Company's common stock will begin trading on a split-adjusted basis when the market opens on September 16, 2024. The Company's common stock will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol "ISPC." The new CUSIP number for the Company's common stock following the reverse stock split will be 45032V207.

iSpecimen Inc. (ISPC) Q2 2024 Earnings Call Transcript
seekingalpha.com10 August 2024 Sentiment: NEUTRAL

iSpecimen Inc. (NASDAQ:ISPC ) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Phil Carlson - IR, KCSA Strategic Communications Tracy Curley - CEO and CFO Leslie Hoyt - VP, Operations Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Operator Good morning everyone and welcome to the iSpecimen Second Quarter 2024 Earnings Conference Call. At this time, participants are in a listen-only mode.

iSpecimen Reports Second Quarter 2024 Results
globenewswire.com06 August 2024 Sentiment: POSITIVE

Revenue increased 76% year-over-year to approximately $2.86 million Brielan Smiechowski Named SVP of Sales and Business Development LEXINGTON, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc.  (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three and six month periods ended June 30, 2024.

iSpecimen Inc. (ISPC) Q1 2024 Earnings Call Transcript
Seeking Alpha12 May 2024 Sentiment: POSITIVE

iSpecimen Inc. (NASDAQ: ISPC) Q1 2024 Earnings Conference Call on May 7, 2024 at 8:30 AM ET with company representatives including Phil Carlson, Tracy Curley, and Leslie Hoyt. Conference call participants include Matt Hewitt from Craig Hallum Capital. The call is being recorded.

iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call
GlobeNewsWire12 March 2024 Sentiment: NEGATIVE

The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern

iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript
Seeking Alpha03 November 2023 Sentiment: POSITIVE

iSpecimen Inc. (NASDAQ:ISPC ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Executive Officer and Chief Financial Officer Benjamin Bielak - Chief Information Officer Eric Langlois - Chief Revenue Officer Carly Lejnieks - Vice President of Marketing. Conference Call Participants Matt Hewitt - Craig Hallum Operator Good day, everyone, and welcome to iSpecimens Third Quarter 2020 Results Conference Call.

iSpecimen Inc. (ISPC) Q2 2023 Earnings Call Transcript
Seeking Alpha05 August 2023 Sentiment: POSITIVE

iSpecimen Inc. (NASDAQ:ISPC ) Q2 2023 Earnings Conference Call August 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Executive Officer and Chief Financial Officer Eric Langlois - Chief Revenue Officer Evan Cox - Vice President of Product Management Conference Call Participants Operator Good day, everyone, and welcome to iSpecimen's Second Quarter 2023 Results Conference Call. At this time participants are in a listen-only mode.

iSpecimen Inc. (ISPC) Q1 2023 Earnings Call Transcript
Seeking Alpha06 May 2023 Sentiment: POSITIVE

iSpecimen Inc. (NASDAQ:ISPC ) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Tracy Curley - Chief Executive Officer Benjamin Beilak - Chief Information Officer Eric Langlois - Chief Revenue Officer Conference Call Participants Matt Hewitt - Craig Hallum Capital Group Operator Good morning, and welcome to iSpecimen First Quarter 2023 Earnings Conference Call [Operator Instructions]. Please note that this event is being recorded.

What type of business is iSpecimen?

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

What sector is iSpecimen in?

iSpecimen is in the Healthcare sector

What industry is iSpecimen in?

iSpecimen is in the Diagnostics & Research industry

What country is iSpecimen from?

iSpecimen is headquartered in United States

When did iSpecimen go public?

iSpecimen initial public offering (IPO) was on 17 June 2021

What is iSpecimen website?

https://ispecimen.com

Is iSpecimen in the S&P 500?

No, iSpecimen is not included in the S&P 500 index

Is iSpecimen in the NASDAQ 100?

No, iSpecimen is not included in the NASDAQ 100 index

Is iSpecimen in the Dow Jones?

No, iSpecimen is not included in the Dow Jones index

When was iSpecimen the previous earnings report?

No data

When does iSpecimen earnings report?

Next earnings report date is not announced yet